Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia

Clinical trial NCT06976476 · RECRUITING

Trial details

NCT number: NCT06976476
Sponsor: Memorial Sloan Kettering Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma Hypogammaglobulinemia Hypogammaglobulinemia, Acquired

Start date: 2025-05-08
Primary completion: 2029-05-08
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.